The Oxford-AstraZeneca Covid vaccine is being withdrawn worldwide, the company has said, months after the pharmaceutical firm admitted in court documents that it could lead to a rare, dangerous side effect.
The application to withdraw the vaccine - which means it can no longer be used in the European Union - was made on March 5 and came into effect on Tuesday.
Alongside the EU withdrawal, similar applications are set to be filed UK and other countries that had approved the vaccine, known as Vaxzevria, in the coming months.
An AstraZeneca statement said: "We are incredibly proud of the role Vaxzevria played in ending the global pandemic.
"According to independent estimates, over 6.5 million lives were saved in the first year of use alone and over three billion doses were supplied globally.
"Our efforts have been recognised by governments around the world and are widely regarded as being a critical component of ending the global pandemic.
"As multiple, variant Covid-19 vaccines have since been developed, there is a surplus of available updated vaccines.
"This has led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied.
"AstraZeneca has therefore taken the decision to initiate withdrawal of the marketing authorisations for Vaxzevria within Europe.
"We will now work with regulators and our partners to align on a clear path forward to conclude this chapter and significant contribution to the Covid-19 pandemic."
More to follow...
